Insight into the molecular mechanism of rapamycin's immunosuppressive effects provides the basis for a novel approach to regulating therapeutic gene expression (pages 1028-1032).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rivera, V.M. et al. A humanized system for phar-macologic control of gene expression. Nature Med. 2, 1028–1032 (1996).
Schokett, P., Difilippantonio, M., Hellman, N. & Schatz, D.G. A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice. Proc.Natl. Acad. Sci. USA 92, 6522–6526 (1995).
Brown, M. et al. Lac repressor can regulate expression from a hybrid SV40 early promoter containing a lac operator in animal cells. Cell 49, 603–612 (1987).
Schreiber, S.L. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 251, 283 (1991).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wilson, J. A pharmacologenic rheostat for gene therapy. Nat Med 2, 977–978 (1996). https://doi.org/10.1038/nm0996-977
Issue date:
DOI: https://doi.org/10.1038/nm0996-977
